Corbus Pharmaceutical Holdings, Inc. (CRBP): Up 10% today, Nice!

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Corbus Pharmaceutical Holdings, Inc. (CRBP)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	5
Posts	329
Boards Moderated	0
Alias Born	04/01/2021

Re: None

Friday, 03/01/2024 3:33:36 PM

Friday, March 01, 2024 3:33:36 PM

Up 10% today, Nice!

Bullish

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent CRBP News

Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 08:31:07 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/23/2026 04:15:13 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/11/2026 09:06:17 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/09/2026 08:16:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:03 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:30:18 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 09:08:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:45:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:32:02 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:30:13 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/13/2026 09:02:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:25:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:24:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 12:26:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 09:05:25 PM
Corbus Pharmaceuticals Shares Rise on Encouraging Safety Results for Experimental Obesity Drug • IH Market News • 12/11/2025 01:28:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 12:22:10 PM
Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss • GlobeNewswire Inc. • 12/11/2025 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 01:14:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2025 01:02:14 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/03/2025 01:00:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:34:25 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/30/2025 08:33:20 PM

More CRBP News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow